Pathophysiology of cerebral palsy.

Cerebral palsy (CP), defined as a group of nonprogressive disorders of movement and posture, is the most common cause of severe neurodisability in children. Understanding its physiopathology is crucial to developing some protective strategies. Interruption of oxygen supply to the fetus or brain asphyxia was classically considered to be the main causal factor explaining later CP. However several ante-, peri-, and postnatal factors could be involved in the origins of CP syndromes. Congenital malformations are rarely identified. CP is most often the result of environmental factors, which might interact with genetic vulnerabilities, and could be severe enough to cause the destructive injuries visible with standard imaging (i.e., ultrasonographic study or MRI), predominantly in the white matter in preterm infants and in the gray matter and the brainstem nuclei in full-term newborns. Moreover they act on an immature brain and could alter the remarkable series of developmental events. Biochemical key factors originating in cell death or cell process loss, observed in hypoxic-ischemic as well as inflammatory conditions, are excessive production of proinflammatory cytokines, oxidative stress, maternal growth factor deprivation, extracellular matrix modifications, and excessive release of glutamate, triggering the excitotoxic cascade. Only two strategies have succeeded in decreasing CP in 2-year-old children: hypothermia in full-term newborns with moderate neonatal encephalopathy and administration of magnesium sulfate to mothers in preterm labor.

[1]  K. Nelson Causative Factors in Cerebral Palsy , 2008, Clinical obstetrics and gynecology.

[2]  S. Robinson,et al.  Neonatal loss of γ–aminobutyric acid pathway expression after human perinatal brain injury , 2006 .

[3]  D. Attwell,et al.  Neurotransmitter receptors in the life and death of oligodendrocytes , 2007, Neuroscience.

[4]  J. Volpe Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances , 2009, The Lancet Neurology.

[5]  F. Northington,et al.  A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy. , 2008, American journal of obstetrics and gynecology.

[6]  C. Guerri Neuroanatomical and neurophysiological mechanisms involved in central nervous system dysfunctions induced by prenatal alcohol exposure. , 1998, Alcoholism, clinical and experimental research.

[7]  K. Nelson,et al.  Maternal infection and cerebral palsy in infants of normal birth weight. , 1997, JAMA.

[8]  F. Jensen,et al.  NMDA Receptor Blockade with Memantine Attenuates White Matter Injury in a Rat Model of Periventricular Leukomalacia , 2008, The Journal of Neuroscience.

[9]  G. Escobar,et al.  Chorioamnionitis and cerebral palsy in term and near-term infants , 2004 .

[10]  L. Doyle,et al.  Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. , 2014, The Cochrane database of systematic reviews.

[11]  J. Olney,et al.  Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  A. Maclennan,et al.  Cerebral Palsy and the Application of the International Criteria for Acute Intrapartum Hypoxia , 2006, Obstetrics and gynecology.

[13]  Steven P. Miller,et al.  Recurrent Postnatal Infections Are Associated With Progressive White Matter Injury in Premature Infants , 2008, Pediatrics.

[14]  F. Duffy,et al.  A Three-Center, Randomized, Controlled Trial of Individualized Developmental Care for Very Low Birth Weight Preterm Infants: Medical, Neurodevelopmental, Parenting, and Caregiving Effects , 2003, Journal of developmental and behavioral pediatrics : JDBP.

[15]  S. Back,et al.  Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury , 2008, Annals of neurology.

[16]  M. Johnston,et al.  Sex and the pathogenesis of cerebral palsy , 2006, Developmental medicine and child neurology.

[17]  L. Doyle,et al.  Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. , 2008, The Journal of pediatrics.

[18]  H. Kinney,et al.  Development of microglia in the cerebral white matter of the human fetus and infant , 2006, The Journal of comparative neurology.

[19]  N. Jovanov-Milošević,et al.  The development of cerebral connections during the first 20-45 weeks' gestation. , 2006, Seminars in fetal & neonatal medicine.

[20]  O. Flodmark,et al.  Clinical and MRI correlates of cerebral palsy: the European Cerebral Palsy Study. , 2006, JAMA.

[21]  J. Olney,et al.  Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. , 1999, Science.

[22]  M. Keszler,et al.  Cooling for Newborns with Hypoxic Ischemic Encephalopathy , 2013, Neonatology.

[23]  D. Ferriero,et al.  Molecular and biochemical mechanisms of perinatal brain injury. , 2001, Seminars in neonatology : SN.

[24]  Jamel Chelly,et al.  Human disorders of cortical development: from past to present , 2006, The European journal of neuroscience.

[25]  A. Hjern,et al.  Perinatal complications and socio-economic differences in cerebral palsy in Sweden – a national cohort study , 2008, BMC pediatrics.

[26]  B. Berger,et al.  Origins of Cortical GABAergic Neurons in the Cynomolgus Monkey , 2008, Cerebral cortex.

[27]  J. Kurinczuk,et al.  Antepartum risk factors for newborn encephalopathy: the Western Australian case-control study , 1998 .

[28]  A. Gunn,et al.  Hypoxic-ischemic brain injury in the newborn: pathophysiology and potential strategies for intervention. , 2001, Seminars in neonatology : SN.

[29]  Antenatal Magnesium Sulfate and Neurologic Outcome in Preterm Infants: A Systematic Review , 2009, Obstetrics and gynecology.

[30]  S. Robinson,et al.  Neonatal loss of gamma-aminobutyric acid pathway expression after human perinatal brain injury. , 2006, Journal of neurosurgery.

[31]  M. Kaminski,et al.  Prenatal Risk Factors for Cerebral Palsy in Very Preterm Singletons and Twins , 2005, Obstetrics and gynecology.

[32]  J. Ellenberg,et al.  The Risk of Mortality or Cerebral Palsy in Twins: A Collaborative Population-Based Study , 2002, Pediatric Research.

[33]  K. Hemminki,et al.  High familial risks for cerebral palsy implicate partial heritable aetiology. , 2007, Paediatric and perinatal epidemiology.

[34]  W. Stewart,et al.  Disrupted synaptic development in the hypoxic newborn brain , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Triomphe,et al.  Déficiences et handicaps d'origine périnatale : dépistage et prise en charge , 2004 .

[36]  D. Ferriero,et al.  Selective vulnerability in the developing central nervous system. , 2004, Pediatric neurology.

[37]  P. Gressens,et al.  Effect of Ibotenate on Brain Development: An Excitotoxic Mouse Model of Microgyria and Posthypoxic‐like Lesions , 1994, Journal of neuropathology and experimental neurology.

[38]  S. Rees,et al.  White Matter Injury after Repeated Endotoxin Exposure in the Preterm Ovine Fetus , 2002, Pediatric Research.

[39]  D. Attwell,et al.  Glutamatergic signaling in the brain's white matter , 2009, Neuroscience.

[40]  P. Gressens,et al.  Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos , 1993, Nature.

[41]  A. Maclennan,et al.  Antenatal Causes of Cerebral Palsy: Associations Between Inherited Thrombophilias, Viral and Bacterial Infection, and Inherited Susceptibility to Infection , 2003, Obstetrical & gynecological survey.

[42]  P. Leroux,et al.  Effect of Perinatal Alcohol Exposure on Ibotenic Acid-Induced Excitotoxic Cortical Lesions in Newborn Hamsters , 2005, Pediatric Research.

[43]  L. Wright,et al.  Acute neonatal effects of cocaine exposure during pregnancy. , 2005, Archives of pediatrics & adolescent medicine.

[44]  P. Gressens,et al.  Central Role of Microglia in Neonatal Excitotoxic Lesions of the Murine Periventricular White Matter , 2001, Brain pathology.

[45]  M. Kaminski,et al.  Predictors of cerebral palsy in very preterm infants: the EPIPAGE prospective population‐based cohort study , 2010, Developmental medicine and child neurology.

[46]  A. Kirton,et al.  Advances in perinatal ischemic stroke. , 2009, Pediatric neurology.

[47]  S. Girard,et al.  Role of perinatal inflammation in cerebral palsy. , 2009, Pediatric neurology.

[48]  P. Pharoah Prevalence and pathogenesis of congenital anomalies in cerebral palsy , 2007, Archives of Disease in Childhood Fetal and Neonatal Edition.

[49]  J. Bolaños,et al.  Effect of valproate on the metabolism of the central nervous system. , 1997, Life sciences.